The Binding Site
Our Products
The Science
Support
Contact
Select a region
Brazil
Czech Republic
France
Germany
Italy
Netherlands
Portugal
Spain
United Kingdom
US
Select a language
Portuguese (Brazilian)
Select a language
Czech
Select a language
French
Select a language
German
Select a language
Italian
Select a language
Dutch
Select a language
Portuguese (European)
Select a language
Spanish
Select a language
English
Select a language
English
United Kingdom
English
Sign In
Register
Freelite & Hevylite
Analysers and Software
Immunoassays
Manufacturing Components
iStopMM
Monoclonal Gammopathies
The Kidney & Plasma Cell Disorders
Central Nervous System Disorders
Immunodeficiency
Understanding Binding Site Technology
Need assistance?
Technical Support
Resources
Scientific Support
Global Patient Groups
Our Products
The Science
Support
Our Story
Media Enquiries
News and Events
Careers
Privacy policy
Contact
Select a region
Brazil
Czech Republic
France
Germany
Italy
Netherlands
Portugal
Spain
United Kingdom
US
Select a language
Portuguese (Brazilian)
Select a language
Czech
Select a language
French
Select a language
German
Select a language
Italian
Select a language
Dutch
Select a language
Portuguese (European)
Select a language
Spanish
Select a language
English
Select a language
English
United Kingdom
English
Sign In
Register
Home
/
Publications
/
Order Publication
< Publications
Order Publication
Order a publication
Simply fill out this form to order a publication to be sent to you.
First Name*
Last Name*
Job Title*
Laboratory / Institute / Company*
Business Email*
Address*
Country*
Publication*
Reference ranges and cutoff levels of pneumococcal antibody global serum assays (IgG and IgG2) and specific antibodies in healthy children and adults (MKG784)
Clinical comparison of new monoclonal antibody-based nephelometric assays for free light Kappa and Lambda to polyclonal antibody-based assays and immunofixation electrophoresis (MKG655)
Combined analysis using extended renal reference range of serum free light chain ratio and serum protein electrophoresis improves the diagnostic accuracy of multiple myeloma in renal insufficiency. (MKG796)
Comparison of Freelite and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis (MKG885)
Comprehensive diagnostic criteria for IgG4 related disease (MKG800)
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1 (MKG617)
Determining the Clinical Significance of Monoclonal Gammopathy of Undertermined Significance: A SEER - Medicare Population Analysis (MKG815)
Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy (MKG677)
Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. (MKG343)
Evidence-based use of serum protein electrophoresis in laboratory medicine. (MKG742)
Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies: correlation with 24-hr urinary light-chain excretion. (MKG222)
Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients (MKG918)
IgA Kappa/IgA Lambda Heavy/Light Chain Assessment in the management of patients with IgA myeloma (MKG821)
Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma. (MKG715)
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma (MKG879)
International Myeloma Working Group Guidelines for serum free light chain analysis in multiple myeloma and related disorders (MKG514)
International Myeloma Working Group recommendations for global myeloma care (MKG714)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma (MKG780)
Kappa free light chains: diagnostic and prognostic relevance in MS and CIS (MKG848)
Kinetics of IgM and IgA antibody response to 23-valent pneumococcal polysaccharide vaccination in healthy subjects (MKG782)
Monitoring IgA Multiple Myeloma: Immunoglobulin Heavy/Light Chain Assays (MKG787)
Monoclonal Gammopathy of Undetermined Significance and Risk of Lymphoid and Myeloid Malignancies: 728 Cases Followed up to 30 Years in Sweden (MKG716)
Multicenter study for the evaluation of the antibody response against salmonella typhi VI vaccination (EMPATHY) for the diagnosis of anti polysaccharide antibody production deficiency in patients with primary immunodeficiency (MKG864)
Multiple myeloma and infections: a population based study on 9253 multiple myeloma patients (MKG792)
N Latex FLC serum free light chain assays in patients with renal impairment (MKG886)
Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update (MKG408.1)
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study. (MKG608)
Prognostic utility of intact immunoglobulin Ig Kappa/Ig Lambda ratios in multiple myeloma patients (MKG676)
Quantification of IgM and IgA anti pneumococcal capsular polysaccharides by a new ELISA assay: a valuable diagnostic and prognostic tool for common variable immunodeficiency (MKG783)
Quantification of β-region IgA monoclonal Proteins - should we include immunochemical Hevylite® measurements (MKG828)
A multicentre study comparing two methods for serum free light chain analysis (MKG691)
Replacing urine protein electrophoresis with serum free light chain analysis as a first-line test for detecting plasma cell disorders offers increased diagnostic accuracy and potential health benefit to patients (MKG742)
Screening panels for detection of monoclonal gammopathies (MKG535)
Serum Free Light Chain Analysis plus Hevylite 7th Edition (MKG789)
Serum free light chain evaluation as a marker for the impact of intra-clonal heterogeneity on the progression and treatment resistance in multiple myeloma. (MKG746)
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure (MKG493)
Serum free light chains, not urine specimens, should be used to evaluate response in light chain multiple myeloma (MKG906)
Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. (MKG183)
Serum test for assessment of patients with Bence Jones myeloma. (MKG189)
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS (MKG679)
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network (MKG799)
The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma (MKG814)
Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis (MKG516)
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy (MKG816)
Utility of the immunoglobulin free light chain assay for plasma cell disorders (MKG797)
Quantity*
How did you hear about us?
Advertisment
Colleague
Current Customer
Direct Mail
Distributor Referral
Exhibition
Guessed
Journal
Newsletter
Search Engine
Website Advertisement
We take your privacy seriously and will use your data to provide the information you have requested. We may also add your details to our database. For details of our privacy policy, please visit <a href="/privacy-policy" target="_blank">http://www.bindingsite.com/privacy-policy.</a> <br/> Please confirm you have read our privacy policy and agree to the terms.
